Development and characterization of a sy
β
P. Szymanski; K. Anwer; S. M. Sullivan
π
Article
π
2006
π
John Wiley and Sons
π
English
β 155 KB
## Abstract ## Background Systemic administration of nonβviral gene therapy provides better access to tumors than local administration. Development of a promoter that restricts expression of cytotoxic proteins to the tumor vasculature will increase the safety of the system by minimizing expression